Trial
NCT00395057
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Choroid Neovascularization
Intervention
AGN 211745
Why stopped
The study was terminated early due to company decision (non-safety related).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-07